OTTO, manufacturing quality and affordable pharmaceutical products in Indonesia

As a subsidiary of Mensa Group, Otto is a pharmaceutical manufacturing company which produces various high quality pharmaceutical with the aim to serve Indonesian health society. Therefore, good manufacturing practice standard (GMP) and international standards (PIC/S) are important requirements. Currently, we have a production unit for non betalactam, penicillin, and cephalosporin.

With a commitment to grow, we made new investment by setting up a new factory in Lembang, Bandung  with new production facility for tablets, capsules, syrup, dry syrup, creams, sachets of oral and injectable products. We invested approximately US$ 28 million and appointed a world class pharmaceutical manufacturing construction consultant JJ Pharmaplan to design the new  plant  which is scheduled to be completed at the end of 2011 by combining the latest  cGMP standards and best concept for a new formulation facility.

Later, this new formulation plant will have two separate buildings with manufacturing facilities for:

  1. Non Betalactam Group for Non-sterile Therapeutically Drugs & Injectable Oral Solution
  2. Cephalosporin Group for Non-sterile Therapeutically Drugs & Injectable Oral Powder

OUR PRODUCT: CONTINUOUS INNOVATION

We have the philosophy that every drug produced must have a good quality starting from selecting the raw materials, production process, and packaging always bearing in mind that every drug is for human consumption. With a fairly complex set of products, including generic and non generic, our marketing division covers the entire territory of Indonesia and also some overseas countries such as Singapore, Malaysia, Sudan, Myanmar, Hong Kong, Cambodia, Sri Lanka, and Vietnam.

In addition, we also continue to innovate by following the trends that allow us to move forward accelerating in the market. To complete the portfolio of businesses that are owned at this time, we also entered the osteoporosis business in March 2006 by launching  Hi-Bone products as bone and joint supplement containing  300mg of calcium phosphate. Seeing the business trend of osteoporosis,  we also launched related product namely Hi-Bone 600 containing extra calcium (calcium phosphate, calcium carbonate 300mg and 300mg) in July 2010

OUR SALES FORCE

To win the health market competition in Indonesia, we realized the quality of drug and competent force are the main determining factor. In support to this we regularly organize in house training in the attempt to develop the competence of the entire sales force.

click for more events

Otto Participated in 17th Indonesian National Congress Orthopaedic and Traumatology Association

With the topic “Present and Future Challenge on Shoulder, Ankle and Foot Surgery”, Otto participated in 17th Indonesian National Congress Orthopaedic and Traumatology Association. Here, Otto promoted Hibone® 600 and Viopor® group, the antibiotic product Bioxon®, a proton pump inhibitor (PPI) product Rocer® injection, Rofiden ® product NSAIDs and selective COX-II inhibitors Toramine® product.

Otto Participated in the National Congress of Petri (Indonesian Society for Tropical Diseases) XVI and PKW (Society for Medical Tourism Indonesia) XIII

Otto participated in the National Congress of Petri (Indonesian Society for Tropical Diseases) XVI and PKW (Society for Medical Tourism Indonesia) XIII which was held on July 15-17, 2010 at the Discovery Kuta, Bali-Indonesia. The theme of this congress was “Tropical and Infectious Diseases: From Basic to Clinic for Better Comprehensive Management”.

Otto Participated in the 11th Jakarta Antimicrobial Update (JADE)

March 2010, Otto participated in the 11th Jakarta Antimicrobial Update (JADE) in Jakarta. With the theme “Facing Future Challenges of Emerging Infection: From Prevention to Treatment”, Otto promoted  antibiotic products Such as Biocef®, Opicef®, Tequinol®, Opixime® and Biocepime®, supplement product Opinacea®.

Otto Participated in The Annual Scientific Meeting of Stroke, Neurosonology, Neuroimaging and Neurointervention in March 2010

Otto participated in The Annual Scientific Meeting of Stroke, Neurosonology, Neuroimaging and Neurointervention in March 2010 in Yogyakarta. This event was organized by PERDOSSI (Indonesia Nerve Specialist Doctors Association) with the theme “Toward the New Era of Cerebrovascular Disease Management and Interventional Neurology.” Otto was one of the 25 pharmaceutical companies participated in the exhibition. Otto promoted some of her products such as Serfac®, Bioxon®, Opineuron®, Toramine® and CNS products.

Otto Participated in the 8th Scientific Meeting Respiratory Medicine (PIPKRA)

Early February 2010, Otto participated in the 8th Scientific Meeting Respiratory Medicine (PIPKRA) in Jakarta with theme “New Direction of Respiratory Medicine towards Translational Medicine”. It was attended by Pulmonary Doctors and also doctors from different discipline. Otto promoted its products Such as Biocepime®, Difloxin®, Opinacea®, Tequinol®, Biozim® and Prednicort®.

Follow

Get every new post delivered to your Inbox.